Enovis Corp (NYSE:ENOV)
$ 21.38 +0.23 (+1.09%) Market Cap: 1.23 Bil Enterprise Value: 2.61 Bil PE Ratio: 0 PB Ratio: 0.83 GF Score: 61/100

Enovis Corp at JPMorgan Healthcare Conference Transcript

Jan 13, 2026 / 12:30AM GMT
Release Date Price: $24.66 (-8.50%)
Robbie Marcus
JPMorgan Chase & Co - Analyst

Good afternoon, everyone. Robbie Marcus, the medtech analyst at JPMorgan. Really happy to present our next speaker. Damien McDonald, CEO of Enovis, along with Ben Berry, the CFO. Damien and Ben are going to do a presentation, and I'll come up and we'll do some Q&A afterwards. Over to you, gentlemen.

Damien McDonald
Enovis Corp - Chief Executive Officer, Director

Thanks, Robbie, and thanks for being here everyone. My name's Damien, I'm the CEO. I've been with Enovis now for about 6 months, so I'm looking forward to some engaging questions. And Ben and I will do a little tag team, talk to you about the company. And then let's spend as much time as we can on Q&A and be very interactive with us.

Standard forward-looking Safe Harbor statement so you can read that at your leisure.

Let's talk a little bit about Enovis. We're an orthopedics company but orthopedics was a focus on mobility and the whole continuum of care. I'll come to that in a minute because it's been a journey as we've built

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot